InterCure Ltd. Form 6-K Summary
Business Context and Reporting Period
InterCure Ltd., an Israeli foreign private issuer, filed Form 6-K for August 2022 on August 18, 2022. The filing includes unaudited interim consolidated financial statements and management’s discussion and analysis for the period ended June 30, 2022.
Financial Information
The filing cover page does not provide specific revenue, profit, cash flow, margin, debt, liquidity, or other financial metrics. These details are included in Exhibits 99.3 and 99.4, but the supplied filing text does not reproduce their contents.
Material Changes and Outlook
Exhibit 99.6 is identified as a press release titled “InterCure Reports Record Breaking Second Quarter Financial Results.” The filing text does not provide the underlying results, comparisons with the prior period, guidance, management commentary, risks, contingencies, or unusual items.
Investor Verification Items
- Verify second-quarter and six-month revenue, profitability, cash flow, margins, and operating metrics in the interim financial statements.
- Review the MD&A for changes versus the comparable prior period, liquidity, debt, capital resources, and management’s outlook.
- Examine the press release for the basis and metrics supporting the “record breaking” characterization.
- Review the management information circular and proxy materials for any corporate or shareholder matters.